ARTICLE | Company News
Antares, Leo Pharma sales and marketing update
November 25, 2013 8:00 AM UTC
Antares granted Leo exclusive, U.S. marketing rights to Otrexup methotrexate in dermatological indications. Antares will receive a $5 million upfront payment and is eligible for up to $15 million in...